The Challenge:
Torigen Pharmaceuticals aims to change the way cancer is treated in cats and dogs. Harnessing the power of pets’ immune own systems, Torigen creates a whole-cell vaccine representing a diverse sample of cancerous antigens for individualized immunotherapy treatments. The company needed to make inroads to build awareness among and partner with veterinarians.
![](https://rebelliongroup.com/app/uploads/2024/06/Book-Pages.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Programmatic.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Group-37699-3.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Rectangle-3612-56.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Group-37699-4.png)
The Need:
Veterinarians simply didn’t know the Torigen name or the benefits of its breakthrough cancer therapy. They needed a campaign to build awareness and help their salespeople get a foot a foot in the door at practices.
![](https://rebelliongroup.com/app/uploads/2024/06/Group-37699-2.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Rectangle-3613-30.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Rectangle-3614-22.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Group-37696-5.png)
The Solution:
Through paid media, we targeted veterinarians directly to build website traffic and register for a free trial kit, aiming to get vets to order the product and administer it. At the same time, we created a range of digital and print resources to help train Torigen’s salespeople on selling into veterinary practices
![](https://rebelliongroup.com/app/uploads/2024/06/Rectangle-3612-57.png)
![](https://rebelliongroup.com/app/uploads/2024/06/Rectangle-3612-58.png)
The Results:
.33%
Programmatic average CTR, well above the industry average of .1%
64K
LinkedIn impressions in market, with a CTR of .45%, well above the industry average of .25%, with a total of 4 kits requested.